Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination

Christof Aigner,Martina Gaggl, Sophie Schmidt,Renate Kain,Nicolas Kozakowski,André Oszwald,Zoltán Prohászka,Raute Sunder-Plassmann,Alice Schmidt,Gere Sunder-Plassmann

Kidney international reports（2023）

引用 1|浏览5

暂无评分

摘要

COVID-19 is associated with a higher risk for aHUS/cTMA recurrence when compared to SARS-CoV-2 vaccination. Overall, the incidence of aHUS/cTMA after COVID-19 infection or SARS-CoV-2 vaccination is low and comparable to that described in the literature.

查看译文

关键词

COVID-19,genetic renal disease,hemolytic uremic syndrome,SARS-CoV-2,thrombotic microangiopathy,vaccination

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要